Phosphorous Derivatives As Kinase Inhibitors

Patent No. EP2300013 (titled "Phosphorous Derivatives As Kinase Inhibitors") was filed by Ariad Pharmaceuticals on May 21, 2009. The application was issued on Nov 13, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKJun 5, 2018ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2300013

ARIAD PHARMACEUTICALS
Application Number
EP09751617A
Filing Date
May 21, 2009
Status
Patent Maintained As Amended
Oct 11, 2024
Publication Date
Nov 13, 2024